Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» These biotech names are ripe for takeover: Cramer
These biotech names are ripe for takeover: Cramer
These biotech names are ripe for takeover: Cramer
Submitted by
admin
on August 28, 2013 - 9:50am
Source:
CNBC
News Tags:
M&A
Amgen
ONYX Pharmaceuticals
Medivation
Astellas
Seattle Genetics
Headline:
These biotech names are ripe for takeover: Cramer
Do Not Allow Advertisers to Use My Personal information
